Inventor · Libertyville, IL, US

Mark A. Matulenko

18Patents

5h-index

84Co-inventors

65Inventor score

Filing activity: May 23, 2003 → Sep 26, 2017

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9163017B2	Anti-viral compounds	Human Necessities	60	Active
US8541424B2	Anti-viral compounds	Human Necessities	53	Active
US8691938B2	Anti-viral compounds	Chemistry; Metallurgy	22	Active
US7528134B2	Acetamides and benzamides that are useful in treating sexual dysfunction	Chemistry; Metallurgy	20	Expired
US8937150B2	Anti-viral compounds	Emerging Cross-Sectional Technologies	9	Active
US9452986B2	6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use	Chemistry; Metallurgy	5	Active
US9278922B2	Anti-viral compounds	Human Necessities	4	Active
US9446059B2	Carbidopa and L-dopa prodrugs and methods of use	Chemistry; Metallurgy	4	Active
US7998982B2	Amide derivatives as TRPV1 antagonists	Human Necessities	4	Active
US9006387B2	Anti-viral compounds	Chemistry; Metallurgy	3	Active
US10174061B2	Carbidopa and L-dopa prodrugs and methods of use	Chemistry; Metallurgy	3	Active
US9969693B2	6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use	Chemistry; Metallurgy	2	Active
US8921514B2	Anti-viral compounds	Chemistry; Metallurgy	1	Active
US10028937B2	Anti-viral compounds	Emerging Cross-Sectional Technologies	0	Active
US9586978B2	Anti-viral compounds	Emerging Cross-Sectional Technologies	0	Active
US10039754B2	Anti-viral compounds	Emerging Cross-Sectional Technologies	0	Active
US9783527B2	Indazole ureas and method of use	Human Necessities	0	Active
US9012651B2	TRPV3 modulators	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.